These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 23711183)

  • 1. Training in molecular cytopathology.
    da Cunha Santos G; Saieg MA; Tsao MS
    Cytopathology; 2013 Jun; 24(3):205-7. PubMed ID: 23711183
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular diagnostics and the training of future tissue- and cell-based pathologists.
    Catherwood MA; Schmitt F; Salto-Tellez M
    Cytopathology; 2012 Oct; 23(5):283-5. PubMed ID: 22985226
    [No Abstract]   [Full Text] [Related]  

  • 3. Response from C. Clinton and D.P. Boyd.
    Clinton C; Boyd DP
    Cytopathology; 2013 Jun; 24(3):207. PubMed ID: 23858528
    [No Abstract]   [Full Text] [Related]  

  • 4. Molecular diagnosis on tissues and cells: how it affects training and will affect practice in the future.
    Boyd C; Boyle DP
    Cytopathology; 2012 Oct; 23(5):286-94. PubMed ID: 22846108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applications of fluorescence in situ hybridization in cytopathology: a review.
    Oliveira AM; French CA
    Acta Cytol; 2005; 49(6):587-94. PubMed ID: 16450896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Considerations for standardizing predictive molecular pathology for cancer prognosis.
    Fiorentino M; Scarpelli M; Lopez-Beltran A; Cheng L; Montironi R
    Expert Rev Mol Diagn; 2017 Jan; 17(1):47-55. PubMed ID: 27897454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermal growth factor receptor in glioblastomas: correlation between gene copy number and protein expression.
    Coulibaly B; Nanni I; Quilichini B; Gaudart J; Metellus P; Fina F; Boucard C; Chinot O; Ouafik L; Figarella-Branger D
    Hum Pathol; 2010 Jun; 41(6):815-23. PubMed ID: 20303140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fluorescence in situ hybridization on histologic sections].
    Mrhalová M; Kodet R
    Cesk Patol; 2013 Oct; 49(4):114-22. PubMed ID: 24289480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Molecular Pathology of Lung Cancer.
    Sholl LM
    Surg Pathol Clin; 2016 Sep; 9(3):353-78. PubMed ID: 27523966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applications of fluorescence in situ hybridization techniques in cytopathology.
    Wolman SR
    Cancer; 1997 Aug; 81(4):193-7. PubMed ID: 9292734
    [No Abstract]   [Full Text] [Related]  

  • 11. Epidermal growth factor receptor and HER-2/neu status by immunohistochemistry and fluorescence in situ hybridization in adenocarcinomas of the biliary tree and gallbladder.
    Shafizadeh N; Grenert JP; Sahai V; Kakar S
    Hum Pathol; 2010 Apr; 41(4):485-92. PubMed ID: 20040392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Software program for molecular-genetic diagnosis].
    Vopr Onkol; 2012; 58(4):586. PubMed ID: 23607222
    [No Abstract]   [Full Text] [Related]  

  • 13. Demystifying molecular cytopathology.
    Schmitt FC
    Int J Surg Pathol; 2010 Jun; 18(3 Suppl):213S-215S. PubMed ID: 20484294
    [No Abstract]   [Full Text] [Related]  

  • 14. Reliability of chromogenic in situ hybridization for epidermal growth factor receptor gene copy number detection in non-small-cell lung carcinomas: a comparison with fluorescence in situ hybridization study.
    Yoo SB; Lee HJ; Park JO; Choe G; Chung DH; Seo JW; Chung JH
    Lung Cancer; 2010 Mar; 67(3):301-5. PubMed ID: 19505745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorescent in situ hybridization mapping of the epidermal growth factor receptor gene in donkey.
    Bugno M; Klukowka-Rötzler J; Słota E; Witarski W; Gerber V; Leeb T
    J Anim Breed Genet; 2007 Jun; 124(3):172-4. PubMed ID: 17550360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermal growth factor receptor (EGFR) gene copy number detection in non-small-cell lung cancer; a comparison of fluorescence in situ hybridization and chromogenic in situ hybridization.
    Gallegos Ruiz MI; Floor K; Vos W; Grünberg K; Meijer GA; Rodriguez JA; Giaccone G
    Histopathology; 2007 Nov; 51(5):631-7. PubMed ID: 17927584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and Cost Implications of Universal Versus Locally Advanced-Stage and Advanced-Stage-Only Molecular Testing for Epidermal Growth Factor Receptor Mutations and Anaplastic Lymphoma Kinase Rearrangements in Non-Small Cell Lung Carcinoma: A Tertiary Academic Institution Experience.
    Sauter JL; Butnor KJ
    Arch Pathol Lab Med; 2016 Apr; 140(4):358-61. PubMed ID: 27028394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selecting lung cancer patients for treatment with epidermal growth factor receptor tyrosine kinase inhibitors by immunohistochemistry and fluorescence in situ hybridization--why, when, and how?
    Dziadziuszko R; Hirsch FR; Varella-Garcia M; Bunn PA
    Clin Cancer Res; 2006 Jul; 12(14 Pt 2):4409s-4415s. PubMed ID: 16857819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In situ hybridization in molecular pathological diagnostics].
    Schildhaus HU
    Pathologe; 2020 Nov; 41(6):561-562. PubMed ID: 33095304
    [No Abstract]   [Full Text] [Related]  

  • 20. First-generation epidermal growth factor receptor inhibitors in non-small cell lung cancer: clinical impact of the epidermal growth factor receptor fluorescence in situ hybridization assay.
    Hirsch FR; Dziadziuszko R; Varella-Garcia M; Franklin WA; Gandara DR; Bunn PA
    J Thorac Oncol; 2008 Jun; 3(6 Suppl 2):S138-42. PubMed ID: 18520298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.